Cargando…
The natural compound n-butylidenephthalide kills high-grade serous ovarian cancer stem cells by activating intrinsic apoptosis signaling pathways
High-grade serous ovarian cancer (HGSOC) constitutes 80% of ovarian cancer. Cancer stem cells (CSCs) are responsible for most of the tumor metastasis and chemoresistance. n-Butylidenephthalide (BP) is a potential anti-tumor agent for treating a variety of cancers. The aim of this study was to evalua...
Autores principales: | Chang, Yu-Hsun, Wu, Kun-Chi, Ding, Dah-Ching |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100814/ https://www.ncbi.nlm.nih.gov/pubmed/33976722 http://dx.doi.org/10.7150/jca.51650 |
Ejemplares similares
-
Spontaneous Transformation of a p53 and Rb-Defective Human Fallopian Tube Epithelial Cell Line after Long Passage with Features of High-Grade Serous Carcinoma
por: Chang, Yu-Hsun, et al.
Publicado: (2022) -
The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3
por: Tsai, Nu-Man, et al.
Publicado: (2006) -
Adipose-derived Stem Cells Stimulated with
n-Butylidenephthalide Exhibit Therapeutic Effects in a Mouse Model of
Parkinson’s Disease
por: Chi, Kang, et al.
Publicado: (2018) -
Induction of Apoptosis Coupled to Endoplasmic Reticulum Stress in Human Prostate Cancer Cells by n-butylidenephthalide
por: Chiu, Sheng-Chun, et al.
Publicado: (2012) -
The organoid: A research model for ovarian cancer
por: Chang, Yu-Hsun, et al.
Publicado: (2021)